Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: A systematic review and meta-analysis

JAMA Surgery

Volumn 148, Issue 7, 2013, Pages 675-686

  Brotman, Daniel J ^a,c   Shihab, Hasan M ^b   Prakasa, Kalpana R ^a   Kebede, Sosena ^a   Haut, Elliott R ^a   Sharma, Ritu ^b   Shermock, Kenneth ^a,b   Chelladurai, Yohalakshmi ^b   Singh, Sonal ^a,b   Segal, Jodi B ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BARIATRIC SURGERY; BLEEDING; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BARIATRIC SURGERY; COMPARATIVE EFFECTIVENESS RESEARCH; ENOXAPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM;

EID: 84880219394     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.72     Document Type: Review

References (27)

1. Gould MK, Garcia DA, Wren SM, et al American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 141(2)(suppl):e227S- e277S. doi:10.1378/chest.11-2297.
2. Hamad GG, Bergqvist D. Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis. 2007 3(1):97-102.
3. Borch KH, Braekkan SK, Mathiesen EB, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost. 2009 7(5): 739-745.
4. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: ameta-analysis. Circulation. 2008 117(1):93-102.
5. Cook D, Douketis J, Meade M, et al. Critical care: venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care. 2008 12(2): R32. doi:10.1186/cc6810.
6. Pryor HI II, Singleton A, Lin E, Lin P, Vaziri K. Practice patterns in high-risk bariatric venous thromboembolism prophylaxis. Surg Endosc. 2013 27(3):843-848.
7. Singh S, Haut ER, Brotman DJ, et al. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations: Evidence Report/Technology Assessment. Washington, DC: Agency for Healthcare Research & Quality 2013.
8. Downs SH, Black N. The feasibility of creating a checklist for the assessment of themethodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998 52(6):377-384.
9. AHRQ. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality 2008. http://www.ncbi.nlm.nih.gov/books/NBK47095/. Accessed September 1, 2011.
10. Birkmeyer NJ, Finks JF, Carlin AM, et al Michigan Bariatric Surgery Collaborative. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg. 2012 147(11):994-998.
11. Birkmeyer NJ, Finks JF, English WJ, et al Michigan Bariatric Surgery Collaborative. Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery [published online February 8, 2013]. J Hosp Med. doi:10.1002/jhm.2013.
12. Birkmeyer NJ, Share D, Baser O, et al Michigan Bariatric Surgery Collaborative. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg. 2010 252(2):313-318.
13. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002 12(1):19-24.
14. Raftopoulos I, Martindale C, Cronin A, Steinberg J. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc. 2008 22(11):2384-2391.
15. Overby DW, Kohn GP, Cahan MA, et al. Risk-group targeted inferior vena cava filter placement in gastric bypass patients. Obes Surg. 2009 19(4):451-455.
16. Ojo P, Asiyanbola B, Valin E, Reinhold R. Post discharge prophylactic anticoagulation in gastric bypass patient-how safe? Obes Surg. 2008 18(7): 791-796.
17. Obeid FN, Bowling WM, Fike JS, Durant JA. Efficacy of prophylactic inferior vena cava filter placement in bariatric surgery. Surg Obes Relat Dis. 2007 3(6):606-610.
18. Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005 15(10):1368-1374.
19. Gargiulo NJ III, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg. 2006 44(6): 1301-1305.
20. Eriksson S, Backman L, Ljungström KG. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg. 1997 7(4):332-336.
21. Brasileiro AL, Miranda F Jr, Ettinger JE, et al. Incidence of lower limbs deep vein thrombosis after open and laparoscopic gastric bypass: a prospective study. Obes Surg. 2008 18(1):52-57.
22. Borkgren-Okonek MJ, Hart RW, Pantano JE, et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis. 2008 4(5):625-631.
23. Singh K, Podolsky ER, Um S, et al. Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg. 2012 22(1):47-51.
24. Li W, Gorecki P, Semaan E, Briggs W, Tortolani AJ, D'Ayala M. Concurrent prophylactic placement of inferior vena cava filter in gastric bypass and adjustable banding operations in the Bariatric Outcomes Longitudinal Database. J Vasc Surg. 2012 55(6):1690-1695.
25. Kothari SN, Lambert PJ, Mathiason MA. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg. 2007 194:709-711.
26. ASBMS position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery website. 2007. http://s3.amazonaws.com/publicASMBS/GuidelinesStatements/PositionStatement/ vte-statement.pdf. Accessed December 15, 2012.
27. Becattini C, Agnelli G, Manina G, Noya G, Rondelli F. Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis. 2012 8(1):108-115.